Rasagiline Tablet
Product Images NDC 47781-683

3 FDA label images from Alvogen, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Rasagiline (NDC 47781-683). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alvogen, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rasagiline 0pt5mg Label

Rasagiline 0pt5mg Label
Label for Rasagiline Tablets 0.5 mg oral tablets, distributed by Alvogen, Inc. The package contains 30 tablets. Manufactured by Orion Pharmaceuticals Private Limited, India. The label includes dosage instructions to see accompanying prescribing information and storage guidelines. A barcode is shown on the right side of the label.*
FDA Label Image

Rasagiline 1mg Label

Rasagiline 1mg Label
Rasagiline Tablets 1 mg oral tablets label by Alvogen, Inc. The label specifies 30 tablets per package and indicates the product contains rasagiline mesylate equivalent to 1 mg rasagiline. It includes storage instructions, child-resistant packaging details, and manufacturer information for Orion Pharmaceuticals, India. The label features the NDC 47781-690-30 and barcode.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Rasagiline, showing a bicyclic indane moiety attached to an amine group linked to a propargyl side chain, accompanied by a methanesulfonic acid (CH3SO3H) moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.